Zymeworks: Funding, Investors & Team (Sep 2026)
Zymeworks is a biotech company that uses computational methods to improve therapeutic antibodies and other protein-based treatments. The company is dedicated to creating top-notch protein therapies to combat cancer, autoimmune disorders, and inflammatory diseases. Zymeworks employs their own specialized software and powerful computing to simulate and optimize proteins, making in silico experiments and predictions possible. With this approach, Zymeworks has successfully developed several platform technologies to enhance biologics drug discovery and optimization. The company was established in 2004 and is located in Vancouver, British Columbia.
Zymeworks has raised $221M across 2 funding rounds on record, the most recent an undisclosed round of $183M announced in Mar 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Zymeworks Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Zymeworks Funding Rounds
Zymeworks raised $37.7M in an undisclosed round announced in Dec 2023.
2.3 years later, an undisclosed round of $183M was announced in Mar 2026.
Zymeworks Founders and Leadership Team
Contact details for the Zymeworks team: 1 has a LinkedIn profile.
Start 14-day free trial →Zymeworks Funding Compared to Other Biotechnology Startups
Zymeworks' latest round of $183M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Zymeworks in Biotechnology and Vancouver
Companies Similar to Zymeworks
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Zymeworks Funding FAQs
What does Zymeworks do?
Zymeworks is a biotech company that uses computational methods to improve therapeutic antibodies and other protein-based treatments. The company is dedicated to creating top-notch protein therapies to combat cancer, autoimmune disorders, and inflammatory diseases. Zymeworks employs their own specialized software and powerful computing to simulate and optimize proteins, making in silico experiments and predictions possible. With this approach, Zymeworks has successfully developed several platform technologies to enhance biologics drug discovery and optimization. The company was established in 2004 and is located in Vancouver, British Columbia.
How much funding has Zymeworks raised?
Zymeworks has raised $221M across 2 rounds on record. The most recent is an undisclosed round of $183M announced in Mar 2026.
When did Zymeworks last raise funding?
Zymeworks' most recent funding round on record is an undisclosed round of $183M, announced in Mar 2026.
Who founded Zymeworks?
FundedIQ lists Kenneth Galbraith (Founder) at Zymeworks.
Who is the CEO of Zymeworks?
Ali Tehrani is listed as CEO at Zymeworks.
Where is Zymeworks headquartered?
Zymeworks is based in Vancouver, British Columbia, Canada.
How many employees does Zymeworks have?
Zymeworks is in the 251-500 employee band.
How does Zymeworks' funding compare to other Biotechnology startups?
Zymeworks' latest round of $183M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Zymeworks Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Zymeworks is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.